Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.

Oh JY, Cunningham MC, Beldavs ZG, Tujo J, Moore SW, Thomas AR, Cieslak PR.

Infect Control Hosp Epidemiol. 2012 May;33(5):439-45. doi: 10.1086/665317. Epub 2012 Mar 21.

PMID:
22476268
2.
3.

The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.

Tedja R, Gordon SM, Fatica C, Fraser TG.

Infect Control Hosp Epidemiol. 2014 Feb;35(2):164-8. doi: 10.1086/674856. Epub 2013 Dec 23.

PMID:
24442079
4.

Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.

Theodoro D, Olsen MA, Warren DK, McMullen KM, Asaro P, Henderson A, Tozier M, Fraser V.

Acad Emerg Med. 2015 Sep;22(9):1048-55. doi: 10.1111/acem.12744.

5.

Assessment of the quality of publicly reported central line-associated bloodstream infection data in Colorado, 2010.

Rich KL, Reese SM, Bol KA, Gilmartin HM, Janosz T.

Am J Infect Control. 2013 Oct;41(10):874-9. doi: 10.1016/j.ajic.2012.12.014. Epub 2013 Mar 14.

PMID:
23498552
6.

Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Mar 4;60(8):243-8.

7.

Accuracy of hospital administrative data in reporting central line-associated bloodstream infections in newborns.

Patrick SW, Davis MM, Sedman AB, Meddings JA, Hieber S, Lee GM, Stillwell TL, Chenoweth CE, Espinosa C, Schumacher RE.

Pediatrics. 2013 Mar;131 Suppl 1:S75-80. doi: 10.1542/peds.2012-1427i.

8.

Investigating systematic misclassification of central line-associated bloodstream infection (CLABSI) to secondary bloodstream infection during health care-associated infection reporting.

Thompson ND, Yeh LL, Magill SS, Ostroff SM, Fridkin SK.

Am J Med Qual. 2013 Jan-Feb;28(1):56-9. doi: 10.1177/1062860612442565. Epub 2012 Jun 7.

PMID:
22679125
9.

Risk factors for central line-associated bloodstream infection in pediatric intensive care units.

Wylie MC, Graham DA, Potter-Bynoe G, Kleinman ME, Randolph AG, Costello JM, Sandora TJ.

Infect Control Hosp Epidemiol. 2010 Oct;31(10):1049-56. doi: 10.1086/656246.

PMID:
20731595
10.

Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries.

Rosenthal VD, Maki DG, Rodrigues C, Alvarez-Moreno C, Leblebicioglu H, Sobreyra-Oropeza M, Berba R, Madani N, Medeiros EA, Cuéllar LE, Mitrev Z, Dueñas L, Guanche-Garcell H, Mapp T, Kanj SS, Fernández-Hidalgo R; International Nosocomial Infection Control Consortium Investigators.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1264-72. doi: 10.1086/657140. Epub 2010 Oct 28.

PMID:
21029008
11.

Risk factors for central line-associated bloodstream infections in the era of best practice.

Lissauer ME, Leekha S, Preas MA, Thom KA, Johnson SB.

J Trauma Acute Care Surg. 2012 May;72(5):1174-80. doi: 10.1097/TA.0b013e31824d1085.

PMID:
22673242
12.

Influence of state laws mandating reporting of healthcare-associated infections: the case of central line-associated bloodstream infections.

Pakyz AL, Edmond MB.

Infect Control Hosp Epidemiol. 2013 Aug;34(8):780-4. doi: 10.1086/671280. Epub 2013 Jun 18.

PMID:
23838217
13.

Validation of central line-associated bloodstream infection data in a voluntary reporting state: New Mexico.

Thompson DL, Makvandi M, Baumbach J.

Am J Infect Control. 2013 Feb;41(2):122-5. doi: 10.1016/j.ajic.2012.03.039. Epub 2012 Oct 4.

PMID:
23040607
14.

A survey of preventive measures used and their impact on central line-associated bloodstream infections (CLABSI) in intensive care units (SPIN-BACC).

Gonzales M, Rocher I, Fortin E, Fontela P, Kaouache M, Tremblay C, Frenette C, Quach C.

BMC Infect Dis. 2013 Dec 1;13:562. doi: 10.1186/1471-2334-13-562.

15.
16.

Trends in validity of central line-associated bloodstream infection surveillance data, New York State, 2007-2010.

Hazamy PA, Van Antwerpen C, Tserenpuntsag B, Haley VB, Tsivitis M, Doughty D, Gase KA, Tucci V, Stricof RL.

Am J Infect Control. 2013 Dec;41(12):1200-4. doi: 10.1016/j.ajic.2013.06.006. Epub 2013 Sep 12.

PMID:
24035214
17.

Can inpatient hospital experiences predict central line-associated bloodstream infections?

Saman DM, Kavanagh KT, Johnson B, Lutfiyya MN.

PLoS One. 2013;8(4):e61097. doi: 10.1371/journal.pone.0061097. Epub 2013 Apr 5.

18.

Impact of State Reporting Laws on Central Line-Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units.

Liu H, Herzig CTA, Dick AW, Furuya EY, Larson E, Reagan J, Pogorzelska-Maziarz M, Stone PW.

Health Serv Res. 2017 Jun;52(3):1079-1098. doi: 10.1111/1475-6773.12530. Epub 2016 Jul 24.

PMID:
27451968
19.

[Quality indicators in an intensive care unit: a two-year healthcare-associated infection surveillance program].

Pita MJ, Díaz-Agero C, Robustillo A, Prieto I, Gómez P, Monge V.

Rev Calid Asist. 2012 Mar-Apr;27(2):103-7. doi: 10.1016/j.cali.2011.09.011. Epub 2011 Dec 15. Spanish.

PMID:
22177693
20.

Validation of statewide surveillance system data on central line-associated bloodstream infection in intensive care units in Australia.

McBryde ES, Brett J, Russo PL, Worth LJ, Bull AL, Richards MJ.

Infect Control Hosp Epidemiol. 2009 Nov;30(11):1045-9. doi: 10.1086/606168.

PMID:
19803720

Supplemental Content

Support Center